Literature DB >> 201648

The characterization of SV40-transformed cell lines derived from mouse teratocarcinoma: growth properties and differentiated characteristics.

W Topp, J D Hall, D Rifkin, A J Levine, R Pollack.   

Abstract

Mouse teratocarcinoma cells derived from embryoid bodies of 129SVsl mice were cultured in vitro to permit their differentiation. These cells were then infected with simiam virus 40 (SV40) and 31 cloned cell lines (SVTER) were derived from these cultures. All 31 SVTER cell lines contained the SV40 tumor (T) antigen and grew as permanent lines in culture. Mock-infected embryoid body cultures did not give rise to permanent cell lines. The morphology of each SVTER cell line was distinct and did not change during successive subclonings. The growth properties and tumorigenic potential of all 31 SVTER cell lines were investigated. None of these lines produced tumors in 129SVsl mice. Each cell line was tested for its ability to (1) grow in medium containing 1% serum, (2) plate on cell monolayer, and (3) form clones in methocel suspension. Only three of the SVTER cell lines were transformed with respect to all three of these criteria. Most of these cell lines were minimal transformants. The SVTER cell lines were tested for creatine phospholinase (CPK), an enzyme activity chracteristic of mouse brain and muscle tissue, and the protease, plasminogen activator (PA) which is found in embryoid bodies and several differentiated cell types. Some of the SVTER cell lines contained high levels of CPK, while others had high levels of PA and a third group of cells contained neither enzyme activity. No SVTER cell line was found with high levels of both these enzyme activities. This result suggests that mutually exclusive sets of genes are expressed in these cells as might be expected from the distinct tissue distribution of the two enzyme activities studied. These SVTER cell lines may be useful in reconstructing developmental pathways of differentiating teratomas in vitro.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201648     DOI: 10.1002/jcp.1040930212

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Retroviral vector gene expression in F9 embryonal carcinoma cells.

Authors:  E Linney; S D Neill; D S Prestridge
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells.

Authors:  F K Fujimura; P E Silbert; W Eckhart; E Linney
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

Review 3.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

Review 4.  Tumor viruses and early mouse embryos.

Authors:  F Kelly; H Condamine
Journal:  Biochim Biophys Acta       Date:  1982-04-29

5.  Cytogerontology since 1881: a reappraisal of August Weismann and a review of modern progress.

Authors:  T B Kirkwood; T Cremer
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells.

Authors:  S Segal; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells.

Authors:  F K Fujimura; E Linney
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Transcription of the simian virus 40 genome in DNA-transformed murine teratocarcinoma stem cells.

Authors:  A Linnenbach; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells.

Authors:  K Sekikawa; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells.

Authors:  K Tanaka; K Chowdhury; K S Chang; M Israel; Y Ito
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.